StonvexLoading…
StonvexStonvexStonvexCore line items from SVM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $298.89M | $215.19M | $208.13M | $217.92M |
Operating Income | $103.15M | $63.92M | $33.75M | $62.56M |
Net Income | $78.77M | $49.68M | $21.10M | $43.28M |
EPS (Diluted) | $0.28 | $0.20 | $0.12 | $0.17 |
Total Assets | $1.14B | $702.82M | $676.80M | $723.54M |
Total Liabilities | $305.55M | $105.81M | $96.97M | $103.42M |
Cash & Equivalents | $363.98M | $152.94M | $145.69M | $113.30M |
Free Cash Flow OCF − CapEx | $132.41M | $80.05M | $72.35M | $96.65M |
Shares Outstanding | 38.82M | Not available | Not available | Not available |